Gavin Liu

Gavin has over 15 years of experience in biotechnology with a focus on cancer immunotherapy, cell therapy process development, and CMC. Prior to joining AffyImmune, he led process development efforts on Simcere Pharmaceutical’s first allogeneic CAR-NK product. Gavin has led novel cell therapy pipeline development from platform building to technology transfer through clinical manufacturing, including at Mustang Bio, where he helped transfer Mustang’s first CAR T and gene therapy product for clinical development. Before that, Gavin earned his PhD at Peking University and completed his postdoctoral fellowship at UC San Francisco.